Troy E. Wilson - 17 Aug 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Reporting relationship: President and CEO, Director
Issuer ticker: KURA
Reported as of: 17 Aug 2026
Net transaction value: +$1,112,000
SEC form: 4
Accepted by SEC: 17 Aug 2026, 16:45:03 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: Teresa Bair, Attorney-in-fact for Troy E. Wilson

Key filing fact

Troy E. Wilson filed Form 4 for Kura Oncology, Inc. (KURA) on 17 Aug 2026.

Key facts

This page summarizes Troy E. Wilson's Form 4 filing for Kura Oncology, Inc. (KURA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2026, 16:45.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: +$1,112,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001589597 Primary reporting owner

WILSON TROY EDWARD

Relationship: President and CEO, Director
Address: C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO
Signature: Teresa Bair, Attorney-in-fact for Troy E. Wilson
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KURA transaction

Common Stock

Purchase

Transaction value: $1,112,000
Shares: +100,000
Change %: +36%
Price: $11.12
Shares after: 379,194
Date: 17 Aug 2026
Ownership: by One Fish Two Fish Revocable Trust
Footnotes: F1

KURA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 300,000
Date: 17 Aug 2026
Ownership: by Lorax Charitable Remainder Unitrust

KURA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 435,456
Date: 17 Aug 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.